Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration

Annals of the New York Academy of Sciences

Volumn 1183, Issue , 2010, Pages 149-157

  Finlay, David ^a   Cantrell, Doreen ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

CCR7; CD62L; KLF2; Lymphocytes; Phosphatidylinositol (3,4,5) triphosphate; S1P1

Indexed keywords

CD28 ANTIGEN; CHEMOKINE RECEPTOR CCR7; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7; KRUPPEL LIKE FACTOR; L SELECTIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SPHINGOSINE 1 PHOSPHATE RECEPTOR; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR KLF2; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

CELL METABOLISM; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; LYMPHOCYTE MIGRATION; LYMPHOID TISSUE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW;

MAMMALIA;

EID: 75749119313     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05134.x     Document Type: Review

References (63)

1. Okkenhaug, K., A. Bilancio, J.L. Emery & B. Vanhaesebroeck. 2004. Phosphoinositide 3-kinase in T cell activation and survival. Biochem. Soc. Trans. 32: 332-335.
2. Costello, P.S., M. Gallagher & D.A. Cantrell. 2002. Sustained and dynamic inositol lipidmetabolism inside and outside the immunological synapse. Nat. Immunol. 3: 1082-1089.
3. Harriague, J. & G. Bismuth. 2002. Imaging antigeninduced PI3K activation in T cells. Nat. Immunol. 3: 1090-1096.
4. Huppa, J., M. Gleimer, C. Sumen & M. Davis. 2003. ContinuousTcell receptor signaling required for synapse maintenance and full effector potential. Nat. Immunol. 8: 749-755.
5. Garcon, F. et al. 2008. CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood 111: 1464-1471.
6. Cornish, G.H., L.V. Sinclair & D.A. Cantrell. 2006. Differential regulation of T-cell growth by IL-2 and IL-15. Blood 108: 600-608.
7. Sinclair, L.V. et al. 2008. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat. Immunol. 9: 513-521.
8. Hagenbeek, T.J. et al. 2004. The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling. J. Exp.Med. 200: 883-894.
9. Buckler, J.L. et al. 2006. Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN. J. Immunol. 177: 4262-4266.
10. Harris, S.J., R.V. Parry, J. Westwick & S.G. Ward. 2007. Phosphoinositide lipid phosphatases: Natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes. J. Biol. Chem. 283: 2465-2469.
11. Suzuki, A. et al. 2001. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14: 523-534.
12. Cantrell, D.A. 2003. Regulation and function of serine kinase networks in lymphocytes. Curr. Opin. Immunol. 15: 294-298.
13. Fabre, S. et al. 2005. Stable activation of phosphatidylinositol 3-kinase in the T cell immunological synapse stimulates Akt signaling to FoxO1 nuclear exclusion and cell growth control. J. Immunol. 174: 4161-4171.
14. Palomero,T., M. Dominguez&A.A. Ferrando. 2008. The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia. Cell Cycle 7: 965-970.
15. Hagenbeek, T.J.&H. Spits. 2007. T-cell lymphomas in Tcell-specific Pten-deficient mice originate in the thymus. Leukemia 22: 608-619.
16. Alessi, D.R. et al. 1997. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homologywith theDrosophila DSTPK61 kinase. Curr. Biol. 7: 776-789.
17. Currie, R.A. et al. 1999. Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. Biochem. J. 337(Pt 3): 575-583.
18. Bayascas, J.R. et al. 2008. Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance. Mol. Cell. Biol. 28: 3258-3272.
19. McManus, E.J. et al. 2004. The in vivo role of PtdIns( 3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation. Embo. J. 23: 2071-2082.
20. Milburn, C.C. et al. 2003. Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change. Biochem. J. 375: 531-538.
21. Yang, J. et al. 2002. Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell. 9: 1227-1240.
22. Manning, B. & L. Cantley. 2007. AKT/PKB signaling: Navigating downstream. Cell 129: 1262-1274.
23. Coffer, P.J. & B.M. Burgering. 2004. Forkhead-box transcription factors and their role in the immune system. Nat. Rev. Immunol. 4: 889-899.
24. Burgering, B. 2008. A brief introduction to FOXOlogy. Oncogene 27: 2258-2262.
25. Greiner, E., M. Guppy & K. Brand. 1994. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J. Biol. Chem. 269: 31484-31490.
26. Maciver, N. et al. 2008. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J. Leukoc. Biol. 84: 949-957.
27. Kelly, A.P. et al. 2007.Notch-induced T cell development requires phosphoinositide-dependent kinase 1. Embo. J. 26: 3441-3450.
28. Mao, C. et al. 2007. Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. J. Immunol. 178: 5443-5453.
29. Ciofani, M. & J.C. Zuniga-Pflucker. 2005. Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat. Immunol. 6: 881-888.
30. Juntilla,M.M. et al. 2007. Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. Proc. Natl. Acad. Sci. USA 104: 12105-12110.
31. Rathmell, J.C., R.L. Elstrom, R.M.Cinalli&C.B. Thompson. 2003. Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. Eur. J. Immunol. 33: 2223-2232.
32. Frauwirth, K. et al. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 6: 769-777.
33. Bain, J. et al. 2007. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408: 297-315.
34. Saibil, S. et al. 2007. CD4+ and CD8+ T cell survival is regulated differentially by protein kinase Ctheta, c-Rel, and protein kinase B. J. Immunol. 178: 2932-2939.
35. Park, S.G. et al. 2009. The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappaB and activate T cells. Nat. Immunol. 10: 158-166.
36. Fox, C., P.Hammerman & C. Thompson. 2005. The Pim kinases control rapamycin-resistant T cell survival and activation. J. Exp. Med. 201: 259-266.
37. Jarmin, S. et al. 2008. T cell receptor-induced phosphoinositide-3-kinase p110delta activity is required for T cell localization to antigenic tissue in mice. J. Clin. Invest. 118: 1154-1164.
38. Ward, S. & F. Marelli-Berg. 2009. Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation. Biochem. J. 418: 13-27.
39. Barbee, S.D.&J. Alberola-Ila. 2005. Phosphatidylinositol 3-kinase regulates thymic exit. J. Immunol. 174: 1230-1238.
40. Reif, K. et al. 1996. Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways. Curr. Biol. 6: 1445-1455.
41. Fabre, S. et al. 2008. FOXO1 regulates L-Selectin and a network of human T cell homingmolecules downstream of phosphatidylinositol 3-kinase. J. Immunol. 181: 2980-2989.
42. Kerdiles, Y.M. et al. 2009. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat. Immunol. 10: 176-184.
43. Ouyang,W., O. Beckett, R.A. Flavell & M.O. Li. 2009. An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 30: 358-371.
44. Galkina, E. et al. 2007. T lymphocyte rolling and recruitment into peripheral lymph nodes is regulated by a saturable density of L-selectin (CD62L). Eur. J. Immunol. 37: 1243-1253.
45. Arbones, M.L. et al. 1994. Lymphocyte homing and leukocyte rolling and migration are impaired in Lselectin-deficient mice. Immunity 1: 247-260.
46. Forster, R., A.C. Davalos-Misslitz & A. Rot. 2008. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8: 362-371.
47. Weninger,W., M.A. Crowley, N.Manjunath & U.H. von Andrian. 2001. Migratory properties of naive, effector, andmemory CD8(+) T cells. J. Exp.Med. 194: 953-966.
48. Mora, J. & U. von Andrian. 2006. T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol. 27: 235-243.
49. Unsoeld, H., D. Voehringer, S. Krautwald & H. Pircher. 2005. Constitutive expression of CCR7 directs effector CD8 T cells into the splenic white pulp and impairs functional activity. J. Immunol. 173: 3013-3019.
50. Galkina, E. et al. 2003. L-selectin shedding does not regulate constitutive T cell trafficking but controls the migration pathways of antigen-activated T lymphocytes. J. Exp. Med. 198: 1323-1335.
51. Tu, L. et al. 2002. A functional role for circulating mouse L-selectin in regulating leukocyte/endothelial cell interactions in vivo. J. Immunol. 169: 2034-2043.
52. Kadono, T., G.M. Venturi, D.A. Steeber & T.F. Tedder. 2002. Leukocyte rolling velocities and migration are optimized by cooperative L-selectin and intercellular adhesion molecule-1 functions. J. Immunol. 169: 4542-4550.
53. Venturi, G.M. et al. 2003. Leukocyte migration is regulated by L-selectin endoproteolytic release. Immunity 19: 713-724.
54. Fan, H. & R. Derynck. 1999. Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. Embo. J. 18: 6962-6972.
55. Soond, S.M., B. Everson, D.W. Riches & G. Murphy. 2005. ERK-mediated phosphorylation of Thr735 in TNFalpha-converting enzyme and its potential role in TACE protein trafficking. J. Cell. Sci. 118: 2371-2380.
56. Diaz-Rodriguez, E. et al. 2002. Extracellular signalregulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding.Mol. Biol.Cell. 13: 2031-2044.
57. Okkenhaug, K. et al. 2002. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinasemutant mice. Science 297: 1031-1034.
58. Richards, H. et al. 2008. CD62L (L-selectin) downregulation does not affect memory T cell distribution but failure to shed compromises anti-viral immunity. J. Immunol. 180: 198-206.
59. Chao, C.C., R. Jensen &M.O. Dailey. 1997.Mechanisms of L-selectin regulation by activated T cells. J. Immunol. 159: 1686-1694.
60. Kaech, S.M., S. Hemby, E. Kersh & R. Ahmed. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111: 837-851.
61. Bai, A., H. Hu, M. Yeung & J. Chen. 2007. Kruppellike factor 2 controls T cell trafficking by activating Lselectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. J. Immunol. 178: 7632-7639.
62. Carlson, C.M. et al. 2006. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 442: 299-302.
63. Sebzda, E. et al. 2008. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat. Immunol 9: 233-235.